Markets

Commodities

Currencies

SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus

Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD

IMFINZI® + IMJUDO® improves PFS in early liver cancer

loader